Bosch Packaging Technology, under Germany-based Bosch Group, presents the new GKF
702 expandable capsule filling machine, which will replace the previous GKF 701 model, for the pharmaceutical industry.
“The GKF 702 will continue the success of the previous model. Its performance was upgraded and improved during the re-development process,” explained Product Manager Melanie Beck.
The new model has been designed to produce small batches right in the laboratory. The production parameters required later during production, such as the machine speed, can be fully simulated. “Therefore, the machine is able to produce small batches for research and development or clinical purposes under realistic production conditions,” Ms Beck pointed out.
For laboratory use a specially designed filling station, known as the “Mini-Bowl” was developed for small product batches between 100ml and 300ml, which gives higher powder yields. This offers an economic solution for expensive and limited powder volumes during the development phase. A “slide-gate” system, from the GKF 1400/2500 series, is also available, providing higher batch yields and the option of filling free-flowing granulates, or pellets, via the powder station, the company stated.
The modular design of GKF 702 allows the machine to be re-tooled for any future filling needs and any new developments from Bosch will be compatible with this machine type. For example, the micro-dosing station on the GKF 2500 will soon also be available for the GKF 702, said the company.
Furthermore, the user-friendliness, ergonomics, and the accessibility of the previous GKF 701 machine have been transferred and improved upon in the GKF 702. Most format parts from the GKF 700 and GKF 701, with the exception of the dosing plate in combination with the “slide-gate” system, can also be used on the GKF 702. The new design includes an industrial PC which is 21 CFR part 11 compliant and features a 17″ touch screen. Various interfaces such as LAN, USB and a DVD burner, make batch documentation easier to access.
Source : www.adsalecprj.com
